Journals / Van Tıp Dergisi / 2016 / Cilt: 23 - Sayı: 2

The Isolation of Candida Species from the Samples That Come From the Patients at Intensive Care Unit and Antifungal Susceptibility

Yoğun Bakım Ünitesi'nden Gelen Hasta Örneklerinden İzole Edilen Kandida Türleri ve Antifungal Duyarlılıkları

Pages
143–147
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

According to the results of antifungal susceptibility tests, the resistance rate for fluconazole and itraconazole were 14.6% and 26.6% respectively.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: In this study; we aimed to determine the identification and the antifungal susceptibility testing of yeasts from the samples of the patients that were sent from Anesthesia Intensive Care Unit of Yuzuncu Yil University Education and Research Hospital.
📊
Key Findings & Data:Materials and Methods: The yeasts were identified by using germ tube test, cornmeal tween 80 media, BBL CHROMagar media and API 20C AUX yeast identification system.
💡
Conclusion & Impact:According to the results of antifungal susceptibility tests, the resistance rate for fluconazole and itraconazole were 14.6% and 26.6% respectively.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: In this study; we aimed to determine the identification and the antifungal susceptibility testing of yeasts from the samples of the patients that were sent from Anesthesia Intensive Care Unit of Yuzuncu Yil University Education and Research Hospital. Materials and Methods: The yeasts were identified by using germ tube test, cornmeal tween 80 media, BBL CHROMagar media and API 20C AUX yeast identification system. The antifungal susceptibility tests were performed for amphotericin B, flucytosine, fluconazole and itraconazole by using ATB FUNGUS 2 INT agar microdilution system. Results: 54.6% of the yeasts were identified as C.albicans which was the most common yeast followed by; C.parapsilosis (12%), C.tropicalis (10.6%), C.glabrata (9.3%), Trichosporon spp.(5.3%), C.famata (4%), C.utilis (1.4%), C.kefry (1.4%) and Rhodotorula glutinis (1.4%). According to the results of antifungal susceptibility tests, the resistance rate for fluconazole and itraconazole were 14.6% and 26.6% respectively. However no resistance was detected against amphotericin B and flucytosine. Conclusion: The results of this study show that C.albicans is the most common yeast isolated from the patients at intensive care unit in our hospital. Increase in the resistance of fluconazole and itraconazole which are frequently used for emprical treatment demonstrates the importance of antifungal susceptibility tests.

Özet

Amaç: Bu çalışmada; Yüzüncü Yıl Üniversitesi Eğitim ve Araştırma Hastanesi Anestezi Yoğun Bakım Ünitesi'nde gönderilen hastaların örneklerinden mayaların tanımlanması ve antifungal duyarlılığının belirlenmesi amaçlanmıştır. Gereç ve Yöntem: Maya mantarları; germ tüp testi, mısır unu tween 80 agar ve BBL CHROMagar besiyerleri ile API 20C AUX maya identifikasyon yöntemi kullanılarak tiplendirildi. Amfoterisin B, flusitozin, flukonazol ve itrakonazole karşı antifungal duyarlılıkların saptanmasında ise ATB FUNGUS 2 INT agar mikrodilüsyon sistemi kullanıldı. Bulgular: Mayaların %56.4'ü C. albicans olarak saptanırken, %12'si C.parapsilosis, %10.6'sı C.tropicalis, %9.3'ü C.glabrata, %5.3'ü Trichosporon spp., %4'ü C.famata, %1.4'ü C.utilis, %1.4'ü C.kefry ve %1.4'ü Rhodotorula glutinis bulundu. Antifungal duyarlılık testlerine göre; flukanazole %14.6 ve ıtrakonazole %26.6 oranında direnç saptanırken, Amfoterisin B ve Flusitozine ise direnç saptanmadı. Sonuç: Yapılan çalışma sonucunda, hastanemiz yoğun bakım hastalarında C. albicans'ın en yaygın maya türü olduğu saptanmıştır. Genel olarak direnç gelişim oranındaki düşüklüğe karşın, ampirik tedavide sık kullanılan flukonazol ve itrakonazol direncindeki artış, antifungal duyarlılık testlerinin önemini ortaya koymaktadır.

🔖

Cite This Article

İZCİ, H. Y., BERKTAŞ, M., YAMAN, G., GÜDÜCÜOĞLU, H., ÇIKMAN, A. (2016). The Isolation of Candida Species from the Samples That Come From the Patients at Intensive Care Unit and Antifungal Susceptibility. Van Tıp Dergisi, Cilt: 23 - Sayı: 2, 143–147. https://ajindex.com/articles/334704

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Horn DL, Neofytos D, Anaissie EJ, Fishman JA, Steinbach WJ, Olyaei AJ, et al. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clin Infect Dis 2009; 48(12): 1695-703.
  2. Ruhnke M, Rickerts V, Cornely OA, Buchheidt D, Glöckner A, Heinz W, et al. Diagnosis and therapy of Candida infections: joint recommendations of the German Speaking Mycological Society and the Paul-Ehrlich-Society for Chemotherapy. Mycoses 2011; 54(4): 279- 310. Fridkin SK, Jarvis WR. Epidemiology of nosocomial fungal infections. Clin Microbiol Rev 1996; 9(4): 499-511. Weinstein RA. Nosocomial infection update. Emerg Infect Dis 1998; 4(3): 416-420.
  3. Fridkin SK, Welbel SF, Weinstein RA. Magnitude and prevention of nosocomial infections in the intensive care unit. Infect Dis Clin North Am 1997; 11(2): 479-496.
  4. Koneman EW, Allen SD, Janda WM, Schreckenberger PC, Winn WC, Woods GL, et al. Mycology, In: Koneman EW, Editor. Koneman's Color Atlas and Textbook of Diagnostic Microbiology. Lippincott, USA: Williams and Wilkins Publishers, 2006: 1151- 1144. Tümbay E. Candida türleri. In: S Ustaçelebi Editör. Temel ve Klinik Mikrobiyoloji. Ankara: Güneş Kitabevi, 1999: 1081-1086.
  5. Espinel-Ingroff A, White T, Pfaller MA. Antifungal Agents and Susceptibility Test Methods. In: Murray PR, Baron EJO, Tenover FC, Yolken RH, editors. Manual of Clinical Microbiology. Washington, DC: ASM Pres, 2003: 1859-1880.
  6. Pfaller MA, Rex JH, Rinaldi MG. Antifungal susceptibility testing: Technical advances and potential clinical applications. Clin Infect Dis 1997; 24(5): 776-784.
  7. Kocazeybek B, Ordu A, Ayyıldız A, Aslan M, Bayındır O, Sönmez B. Yoğun bakım Ünitesindeki Hastalardan izole edilen mayalar. Türk Mikrobiyol Cem Derg 2000; 30(1): 38-40.
  8. Doğruman Al F, Aktaş AE, Tuncel E, Ayyıldız A, Uslu H, Aktaş O. Atatürk Üniversitesi Tıp Fakültesi Hastaneleri Mikrobiyoloji laboratuarında klinik örneklerden izole edilen maya türleri. İnfeksiyon Derg 2002; 16(2): 205- 210. Pfaller MA, Jones RN, Doern GV, Sader HS, Hollis RJ, Messer SA. International surveillance of bloodstream infections due to Candida species: frequency of occurrence and antifungal susceptibilities of isolates collected in 1997 in the United States, Canada, and South America for the SENTRY Program. The SENTRY Participant Group. J Clin Microbiol 1998; 36(7): 1886-1889.
  9. Ulutürk R, İnci A, Fincancı M, Tanış M. Çeşitli klinik örneklerden soyutlanan candida türlerinin dağılımı ve antifungal duyarlıl